NCT03307759 Sequencing of Stereotactic Ablative Body Radiotherapy in Combination With PD-1 Blockade Using Pembrolizumab in Metastatic Non-Small Cell Lung Carcinoma Status TERMINATED Phase PHASE1
NCT03299478 Clinical Implementation of TNM-immunoscore in Resected Non-small Cell Lung Cancer Status ACTIVE_NOT_RECRUITING Phase N/A
NCT03296163 A Study Comparing MB02 and Avastin® in Subjects With Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE3
NCT03289962 A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors Status COMPLETED Phase PHASE1
NCT03289780 Clinical Effectiveness Assessment of VeriStrat® Testing and Validation of Immunotherapy Tests in NSCLC Subjects Status ACTIVE_NOT_RECRUITING Phase N/A
NCT03285321 Unresectable Stage IIIA/IIIB Non-small Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE2
NCT03282435 Treatment of Non-small Cell Lung Cancer With Cytokine-induced Killer (CIK) Cells Blocked by PD-1 Antibody Status UNKNOWN Phase PHASE1
NCT03275597 Phase Ib Study of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Non-small Lung Cancer (NSCLC) With Dual Immune Checkpoint Inhibition Status TERMINATED Phase PHASE1
NCT03273790 A Retrospective Study of the Effectiveness and Safety of Nivolumab in Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients in Japan Status COMPLETED Phase N/A
NCT03271554 Treatment Registry of Alectinib in Anaplastic Lymphoma Kinase (ALK)-Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer in Korea Status COMPLETED Phase N/A
NCT03264794 the Clinical Trial of Gefitinib(Non - Small Cell Lung Cancer) Status UNKNOWN Phase PHASE4
NCT03262948 Nab-Paclitaxel Versus Paclitaxel Plus Carboplatin in Advanced Squamous Cell Non Small Cell Lung Cancer Status UNKNOWN Phase PHASE3
NCT03258788 A Translational Study Investigating PD-L1 Expression After Radiotherapy for Non-small Cell Lung Cancer Status COMPLETED Phase N/A
NCT03258671 IMRT and Timing in Combination With EGFRTKI for Stage IV Non-small-cell Lung Cancer Status UNKNOWN Phase NA
NCT03244605 Efficacy Study of Comprehensive Rehabilitation Program in Postoperative NSCLC Patients Status UNKNOWN Phase PHASE3
NCT03242915 Pembrolizumab Plus Chemotherapy in NSCLC With Targetable Genetic Alterations After Progression on Targeted Agents Status COMPLETED Phase PHASE2
NCT03237377 Neoadjuvant Immunoradiation for Resectable Non-Small Cell Lung Cancer Status TERMINATED Phase PHASE2